Donaco International Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Donaco International.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Hospitality earnings growth | 15.2% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
Recent updates
These 4 Measures Indicate That Donaco International (ASX:DNA) Is Using Debt Safely
Oct 11
A Piece Of The Puzzle Missing From Donaco International Limited's (ASX:DNA) Share Price
Aug 26Donaco International (ASX:DNA) Is Doing The Right Things To Multiply Its Share Price
Jul 04Donaco International Limited (ASX:DNA) Doing What It Can To Lift Shares
Apr 24Is Donaco International (ASX:DNA) Using Too Much Debt?
Mar 06Donaco International (ASX:DNA) Is Finding It Tricky To Allocate Its Capital
Jan 31Donaco International (ASX:DNA) Has A Somewhat Strained Balance Sheet
Dec 06Is Donaco International (ASX:DNA) Using Too Much Debt?
Mar 14Does Donaco International (ASX:DNA) Have A Healthy Balance Sheet?
Sep 01Here's Why Donaco International (ASX:DNA) Can Afford Some Debt
Apr 06Robust Earnings May Not Tell The Whole Story For Donaco International (ASX:DNA)
Sep 07Is Donaco International (ASX:DNA) A Risky Investment?
May 26How Much Did Donaco International's(ASX:DNA) Shareholders Earn From Share Price Movements Over The Last Five Years?
Feb 18Here's Why Donaco International (ASX:DNA) Can Afford Some Debt
Dec 25
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Donaco International has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2024 | 40 | 37 | 15 | 15 | N/A |
| 3/31/2024 | 37 | 21 | 15 | 15 | N/A |
| 12/31/2023 | 34 | 6 | 17 | 18 | N/A |
| 9/30/2023 | 29 | -16 | 14 | 14 | N/A |
| 6/30/2023 | 24 | -37 | 9 | 10 | N/A |
| 3/31/2023 | 18 | -41 | 4 | 5 | N/A |
| 12/31/2022 | 11 | -44 | -1 | -1 | N/A |
| 9/30/2022 | 7 | -30 | -3 | -3 | N/A |
| 6/30/2022 | 2 | -16 | -6 | -6 | N/A |
| 3/31/2022 | 4 | -21 | -7 | -7 | N/A |
| 12/31/2021 | 5 | -26 | -9 | -9 | N/A |
| 9/30/2021 | 8 | -1 | -7 | -7 | N/A |
| 6/30/2021 | 10 | 25 | -5 | -5 | N/A |
| 3/31/2021 | 15 | 5 | -7 | -7 | N/A |
| 12/31/2020 | 19 | -15 | -10 | -9 | N/A |
| 9/30/2020 | 36 | -37 | -7 | -6 | N/A |
| 6/30/2020 | 53 | -59 | -4 | -3 | N/A |
| 3/31/2020 | 70 | -111 | 12 | 14 | N/A |
| 12/31/2019 | 87 | -163 | 28 | 31 | N/A |
| 9/30/2019 | 87 | -180 | 24 | 28 | N/A |
| 6/30/2019 | 86 | -198 | 20 | 26 | N/A |
| 3/31/2019 | 87 | -113 | 16 | 23 | N/A |
| 12/31/2018 | 88 | -27 | 12 | 20 | N/A |
| 9/30/2018 | 91 | -76 | 20 | 27 | N/A |
| 6/30/2018 | 93 | -125 | 29 | 35 | N/A |
| 3/31/2018 | 107 | -121 | N/A | 37 | N/A |
| 12/31/2017 | 121 | -118 | N/A | 39 | N/A |
| 9/30/2017 | 129 | -43 | N/A | 43 | N/A |
| 6/30/2017 | 136 | 31 | N/A | 47 | N/A |
| 3/31/2017 | 135 | 55 | N/A | 39 | N/A |
| 12/31/2016 | 134 | 79 | N/A | 31 | N/A |
| 9/30/2016 | 138 | 79 | N/A | 41 | N/A |
| 6/30/2016 | 143 | 79 | N/A | 50 | N/A |
| 3/31/2016 | 111 | 45 | N/A | 55 | N/A |
| 12/31/2015 | 78 | 11 | N/A | 60 | N/A |
| 9/30/2015 | 48 | 3 | N/A | 34 | N/A |
| 6/30/2015 | 19 | -5 | N/A | 9 | N/A |
| 12/31/2014 | 21 | 1 | N/A | -5 | N/A |
| 9/30/2014 | 20 | 3 | N/A | N/A | N/A |
| 6/30/2014 | 21 | 5 | N/A | 10 | N/A |
| 12/31/2013 | 20 | 7 | N/A | 6 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if DNA's forecast earnings growth is above the savings rate (2.6%).
Earnings vs Market: Insufficient data to determine if DNA's earnings are forecast to grow faster than the Australian market
High Growth Earnings: Insufficient data to determine if DNA's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if DNA's revenue is forecast to grow faster than the Australian market.
High Growth Revenue: Insufficient data to determine if DNA's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if DNA's Return on Equity is forecast to be high in 3 years time